NVO
NYSENovo Nordisk A/S
Price
Key statistics
Insider activity
SEC EDGAR ↗No recent Form 4 insider transactions found.
Social sentiment
Volume-weighted across live social sources
$NVO Still trading sharply down in Copenhagen exchange. Down 4% this morning.
Ticker NEXR has barely 550,000 shares outstanding. The only comparable ticker was VEEE and that one ran from 4.10$ to over 51$. NEXR released news on Aug 3rd and is shifting heavily into the AI sector. NEXR has only about 700 watchers on Stocktwits. Took a big position looking to profit massively very soon. $NVO -- -
$NVO Trump doesnt like Denmark, so thsts the reason why he istrying to beat the sheat out of it companies $DJT
$ASTS $SPCX $AMD $NVO $RYCEY AST SpaceMobile advances satellite connectivity, SPCX provides SPAC exposure, AMD benefits from AI chip demand, Novo Nordisk leads obesity treatments, and Rolls-Royce continues benefiting from aerospace recovery.
$NVO They really need to get better in M&A. Man, you are sitting on a ton of cash. MDGL,NBIX, ARWR for the big bucks, MLYS for the repeatingly mentioned "bolt-on". Do something and do it soon.
$NVO
$NVO double beat and raised guidance, 10 pe vs Lilly 100pe... strong buy
$NVO it's all about Greenland 😅
$NVO give me fking $51. I want to sell all my shares
$NVO Remember meta dropped 12% on earnings and has almost recovered in a few days.
$NVO not surprised if it hits5l $50 by next week again
$NVO they have the #1 weight loss pill and their lead continues to expand with more approvals into foreign countries!!! $SPY
Latest news
European shares edge higher as investors await progress in Mideast talks
Temasek-Backed Manipal Health Shares Surge in Indian Trading Debut
Novo Nordisk tumbles as Wegovy sales miss, trial setback overshadow raised outlook
FTSE 100 Live: Next and Glencore provide results boost, SpaceX tumbles
India's Manipal Health jumps 10.5% in market debut, valued at $9 billion
Novo Nordisk Stock Stumbles On A Key Miss As Its Battle With Eli Lilly Heats Up
Novo Nordisk Raises Earnings Guidance. The Stock Sinks.
NVO Stock Drops 6% Despite Raised Guidance As Investors Worry About Injectable GLP-1 Sales Future
Novo Nordisk (CPSE:NOVO B) Reports Mixed ZEUS Phase 3 Results For Ziltivekimab
Novo Nordisk Stock Drops on Wegovy Shortfall
Get insider-buy alerts
Free weekly digest of the most notable SEC insider purchases — plus early access to real-time alerts on your watchlist.